𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Measurement of Serum α1-Acid Glycoprotein and cei-Antitrypsin Desialylation in Liver Disease

✍ Scribed by Nathalie Serbource-Goguel; Michèle Corbic; Serge Erlinger; Geneviève Durand; Jean Agneray; Jeanne Feger


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
415 KB
Volume
3
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


To determine whether the presence of circulating desialylated glycoproteins reflect the existence and/or the severity of liver disease, 73 patients were evaluated with liver biopsies, conventional liver function tests, and the measurement of the degree of desialylation of two glycoproteins al- acid glycoprotein (al-AGP) and al-antitrypsin (al-AT). A combination of two immunological methods, available as routine laboratory tests, was used for the determination of the desialylation of al-AGP and a,-AT. The severity of liver disease was assessed by a clinical classification depending upon the presence or absence of four complications (jaundice, ascites, hepatic encephalopathy, and weight loss). The presence of serum desialylated al-AGP did not allow detection of mild liver disease, but asialoa,-AGP (and to a lesser extent of asialo-al-(AT) correlated with the severity of liver disease. The sensitivity of desialylated a,-AGP in detection of severe liver disease was 65%, and its specificity was 80%.


📜 SIMILAR VOLUMES


Molecular pathogenesis of liver disease
✍ J H Teckman; D Qu; D H Perlmutter 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB

alpha-1-antitrypsin; PiZZ, a1-ATZ phenotype; ER, endoplasmic acts with the target P 1 -P 1 residues of the reactive center loop, reticulum; MHC, major histocompatibility complex. the loop inserts further into the gap in the A sheet, generating From the: Departments of Pediatrics, Cell Biology, and

Serum α1-antitrypsin levels as a marker
✍ Dr. Michael J. Pettei; Jeremiah J. Levine 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 465 KB

The purpose of this study was to evaluate the use of the acute-phase serum protein a,-antitrypsin (a,- AT) compared with the erythrocyte sedimentation rate (ESR), platelet count, and hemoglobin level in screening for inflammation in newly diagnosed and known patients with inflammatory bowel disease